| Original language | English (US) |
|---|---|
| Pages (from-to) | 458-459 |
| Number of pages | 2 |
| Journal | Movement Disorders Clinical Practice |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 1 2017 |
Keywords
- jumpy stump
- psychogenic
- tremor
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Psychogenic “Jumpy Stump”. / Davis, Jennie L.; Kurek, Julie A.; Sethi, Kapil D.; Morgan, John C.
In: Movement Disorders Clinical Practice, Vol. 4, No. 3, 01.05.2017, p. 458-459.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Psychogenic “Jumpy Stump”
AU - Davis, Jennie L.
AU - Kurek, Julie A.
AU - Sethi, Kapil D.
AU - Morgan, John C.
N1 - Funding Information: reports no financial disclosures. J.A.K. has received a speaker’s honoraria from Teva. K.D.S. is employed part time by Merz Pharmaceuticals. He is a consultant for Cynapsus and Auspex. He received grant support from the National Institutes of Health, National Parkinson Foundation, Kyowa, Abbvie, Acadia, Biotie, Serina. He has served as expert witness in welding and metoclopramide litigation. J.C.M. received consulting fees from Acorda, Impax, Lundbeck, Teva, Veloxis, and the National Parkinson Foundation. J.C.M. is a speaker for Impax and Teva. J.C.M. received research support from the National Institutes of Health and the National Parkinson Foundation. J.C.M. served as an expert witness/consultant in various neurological legal cases. Funding Information: Ethical Compliance Statement: We confirm that we have read the journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. Funding Sources and Conflict of Interest: The authors report no sources of funding or conflicts of interest. Financial Disclosures for the previous 12 months: J.L.D. reports no financial disclosures. J.A.K. has received a speaker's honoraria from Teva. K.D.S. is employed part time by Merz Pharmaceuticals. He is a consultant for Cynapsus and Auspex. He received grant support from the National Institutes of Health, National Parkinson Foundation, Kyowa, Abbvie, Acadia, Biotie, Serina. He has served as expert witness in welding and metoclopramide litigation. J.C.M. received consulting fees from Acorda, Impax, Lundbeck, Teva, Veloxis, and the National Parkinson Foundation. J.C.M. is a speaker for Impax and Teva. J.C.M. received research support from the National Institutes of Health and the National Parkinson Foundation. J.C.M. served as an expert witness/consultant in various neurological legal cases.
PY - 2017/5/1
Y1 - 2017/5/1
KW - jumpy stump
KW - psychogenic
KW - tremor
UR - http://www.scopus.com/inward/record.url?scp=85067375649&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067375649&partnerID=8YFLogxK
U2 - 10.1002/mdc3.12423
DO - 10.1002/mdc3.12423
M3 - Article
AN - SCOPUS:85067375649
VL - 4
SP - 458
EP - 459
JO - Movement Disorders Clinical Practice
JF - Movement Disorders Clinical Practice
SN - 2330-1619
IS - 3
ER -